UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion

Diabetes (New York, N.Y.), 2000-03, Vol.49 (3), p.424-430

2000

Volltextzugriff (PDF)

Inflammatory mechanisms in diabetes: lessons from the β-cell

International Journal of Obesity, 2003-12, Vol.27 (3), p.S12-S16

2003

Volltextzugriff (PDF)

Regulation of insulin secretion from novel engineered insulinoma cell lines

Diabetes (New York, N.Y.), 1997-06, Vol.46 (6), p.968-977

1997

Volltextzugriff (PDF)

Engineered cell lines for insulin replacement in diabetes: current status and future prospects

Diabetologia, 1997-07, Vol.40 Suppl 2, p.S42-S47

1997

Volltextzugriff (PDF)

Regulation of insulin secretion from novel engineered insulinoma cell lines

Diabetes (New York, N.Y.), 1997-06, Vol.46 (6), p.968-977

1997

Volltextzugriff (PDF)

Expression of the Transcription Factor STAT-1α in Insulinoma Cells Protects against Cytotoxic Effects of Multiple Cytokines

The Journal of biological chemistry, 2001-01, Vol.276 (1), p.766-772

2001

Volltextzugriff (PDF)

Cell lines derived from pancreatic islets

Molecular and cellular endocrinology, 2004-12, Vol.228 (1), p.121-128

2004

Volltextzugriff (PDF)

Pro- and Antiapoptotic Proteins Regulate Apoptosis but Do Not Protect Against Cytokine-Mediated Cytotoxicity in Rat Islets and β-Cell Lines

Diabetes (New York, N.Y.), 2006-05, Vol.55 (5), p.1398-1406

2006

Volltextzugriff (PDF)

Selection of insulinoma cell lines with resistance to interleukin-1beta- and gamma-interferon-induced cytotoxicity

Diabetes (New York, N.Y.), 2000-04, Vol.49 (4), p.562-570

2000

Volltextzugriff (PDF)

Cholinergic augmentation of insulin release requires ankyrin-B

Science signaling, 2010-03, Vol.3 (113), p.ra19

2010

Volltextzugriff (PDF)

Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1beta- induced cytotoxicity and reduces nitric oxide production

The Journal of clinical investigation, 1998-05, Vol.101 (9), p.1811-1820

1998

Volltextzugriff (PDF)

Discrete and Complementary Mechanisms of Protection of β-Cells Against Cytokine-Induced and Oxidative Damage Achieved by bcl-2 Overexpression and a Cytokine Selection Strategy

Diabetes (New York, N.Y.), 2003-06, Vol.52 (6), p.1423-1432

2003

Volltextzugriff (PDF)

Islets for all?

Nature biotechnology, 2005-10, Vol.23 (10), p.1231-1232

2005

Volltextzugriff (PDF)

Enhanced cAMP Protein Kinase A Signaling Determines Improved Insulin Secretion in a Clonal Insulin-Producing β-Cell Line (INS-1 832/13)

Molecular endocrinology (Baltimore, Md.), 2004-09, Vol.18 (9), p.2312-2320

2004

Volltextzugriff (PDF)

Inflammatory mechanisms in diabetes: lessons from the -cell

International Journal of Obesity, 2003-12, Vol.27 (S3), p.S12-S16

2003

Volltextzugriff (PDF)

Inflammatoty mechanisms in diabetes: lessons from the ®-cell

Ozhirenie i metabolizm, 2004-03, Vol.1 (1), p.40-40

2004

Volltextzugriff (PDF)

Understanding of basic mechanisms of beta-cell function and survival: prelude to new diabetes therapies

Cell biochemistry and biophysics, 2004, Vol.40 (3 Suppl), p.159-167

2004

Volltextzugriff (PDF)

Identification of genes involved in glucose-stimulated insulin secretion

Diabetes (New York, N.Y.), 2001-02, Vol.50 (suppl 1), p.S134

2001

Volltextzugriff (PDF)

Insulinsezernierende Zellen zur Therapie des Diabetes mellitus

Die Naturwissenschaften, 1996-01, Vol.83 (1), p.1-5

1996

Volltextzugriff (PDF)

Engineered cell lines for insulin replacement in diabetes : current status and future prospects : Insulin: action and secretion

Diabetologia (Berlin), 1997, Vol.40, p.S42-S47

1997

Volltextzugriff (PDF)

Insulin producing cells as therapy in diabetes mellitus

Die Naturwissenschaften, 1996-01, Vol.83 (1), p.1-5

1996

Volltextzugriff (PDF)

Studies on human porin. V. The expression of "porin31HL" in the plasmalemma is not by cell transformation

Biological chemistry Hoppe-Seyler, 1991-08, Vol.372 (8), p.565

1991

Volltextzugriff (PDF)

APOL1-mediated monovalent cation transport contributes to APOL1-mediated podocytopathy in kidney disease

The Journal of clinical investigation, 2024-03, Vol.134 (5)

2024

Volltextzugriff (PDF)

Induction of miR-132 and miR-212 Expression by Glucagon-Like Peptide 1 (GLP-1) in Rodent and Human Pancreatic β-Cells

Molecular endocrinology (Baltimore, Md.), 2015-09, Vol.29 (9), p.1243-1253

2015

Volltextzugriff (PDF)

APOL1-mediated monovalent cation transport contributes to APOL1-mediated podocytopathy in kidney disease

The Journal of clinical investigation, 2024-03, Vol.134 (5), p.1-19

2024

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(32)
Tagungsberichte
(1)

Sprache

Englisch
(30)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Animals
(18)
Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Humans
(14)
Insulin Secretion
(12)
Endocrinology & Metabolism
(11)
Insulin - Metabolism
(11)
Rats
(10)
Islets Of Langerhans - Drug Effects
(8)
Cell Line
(6)
Glucose - Pharmacology
(6)
Transfection
(6)
Tumor Cells, Cultured
(6)
Biological And Medical Sciences
(5)
Islets Of Langerhans - Metabolism
(5)
Cell Biology
(4)
Cytokines - Pharmacology
(4)
Diabetes. Impaired Glucose Tolerance
(4)
Endocrine Pancreas. Apud Cells
(4)
Endocrinopathies
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion

Inflammatory mechanisms in diabetes: lessons from the β-cell

Regulation of insulin secretion from novel engineered insulinoma cell lines

Engineered cell lines for insulin replacement in diabetes: current status and future prospects

Regulation of insulin secretion from novel engineered insulinoma cell lines

Expression of the Transcription Factor STAT-1α in Insulinoma Cells Protects against Cytotoxic Effects of Multiple Cytokines

Cell lines derived from pancreatic islets

Pro- and Antiapoptotic Proteins Regulate Apoptosis but Do Not Protect Against Cytokine-Mediated Cytotoxicity in Rat Islets and β-Cell Lines

Selection of insulinoma cell lines with resistance to interleukin-1beta- and gamma-interferon-induced cytotoxicity

Cholinergic augmentation of insulin release requires ankyrin-B

Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1beta- induced cytotoxicity and reduces nitric oxide production

Discrete and Complementary Mechanisms of Protection of β-Cells Against Cytokine-Induced and Oxidative Damage Achieved by bcl-2 Overexpression and a Cytokine Selection Strategy

Islets for all?

Enhanced cAMP Protein Kinase A Signaling Determines Improved Insulin Secretion in a Clonal Insulin-Producing β-Cell Line (INS-1 832/13)

Inflammatory mechanisms in diabetes: lessons from the -cell

Inflammatoty mechanisms in diabetes: lessons from the ®-cell

Understanding of basic mechanisms of beta-cell function and survival: prelude to new diabetes therapies

Identification of genes involved in glucose-stimulated insulin secretion

Insulinsezernierende Zellen zur Therapie des Diabetes mellitus

Engineered cell lines for insulin replacement in diabetes : current status and future prospects : Insulin: action and secretion

Insulin producing cells as therapy in diabetes mellitus

Studies on human porin. V. The expression of "porin31HL" in the plasmalemma is not by cell transformation

APOL1-mediated monovalent cation transport contributes to APOL1-mediated podocytopathy in kidney disease

Induction of miR-132 and miR-212 Expression by Glucagon-Like Peptide 1 (GLP-1) in Rodent and Human Pancreatic β-Cells

APOL1-mediated monovalent cation transport contributes to APOL1-mediated podocytopathy in kidney disease

Suchergebnisse filtern